Anuh Pharma Share Price
Small Cap | Pharmaceuticals and health care | NSE: ANUHPHR | BSE: 506260
₹153.40 -0.20 (-0.13 %)
Last Updated: 13 Mar 2025 12:00 AM
Overview
Open (₹) 158.30
High (₹) 158.30
Low (₹) 153.25
Prev. Close (₹) 153.60
Volume 5,739
VWAP (₹) 155.24
ROCE (%) 26.84
Industry P/E 43.95
TTM P/E 15.29
P/B Ratio 2.64
Market Cap (₹) Cr.769.32
Dividend Yield (%)1.63
EPS (₹) 11.98
ROE20.62%
Sales Growth (%) 22.66
Profit Growth (%)66.00
Day Range
158.30158.30
52 Week Range
151.00265.00
Historical Returns
Returns (6M)
-28 %
Returns (1Y)
-32.6 %
Returns (3Y)
66.11 %
Returns (5Y)
164.8 %
Returns (6M)
-28 %
Returns (1Y)
-32.6 %
Returns (3Y)
66.11 %
Returns (5Y)
164.8 %
SWOT Analysis
Technicals
Technical Rating
RSI 11.84
MFI 13.25
ATR 7.18
Commodity Channel Index -96.00
ROC125 -23.84
ROC21 -20.81
Williams %R -99.04
Resistance & Support
Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
---|---|---|---|---|---|---|---|
Current | 157.19 | 160.22 | 161.94 | 155.47 | 152.44 | 150.72 | 147.69 |
Week Ago | 164.86 | 166.58 | 168.01 | 163.43 | 161.71 | 160.28 | 158.56 |
Month Ago | 197.06 | 202.98 | 206.61 | 193.43 | 187.51 | 183.88 | 177.96 |
EMA & SMA
153.40
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
20
5 Day 160.58
9 Day 161.33
10 Day 162.81
12 Day 166.79
14 Day 168.76
20 Day 178.39
26 Day 182.56
50 Day 198.64
100 Day 200.05
200 Day 211.51
Deals & Announcements
Bulk and Block Deals
Insider Trading
Date | Name | Action | Avg. Price | Quantity | Deal Value |
---|---|---|---|---|---|
03 Sept, 2024 | BIJAL KAUSHAL SHROFF | Disposal | ₹202.81 | 3,579 | BSE |
03 Sept, 2024 | BIJAL KAUSHAL SHROFF Revised | Disposal | ₹202.60 | 2,521 | BSE |
02 Sept, 2024 | BIJAL KAUSHAL SHROFF | Disposal | ₹202.60 | 2,521 | BSE |
27 Feb, 2024 | ROHAN MAHESH SHAH | Disposal | ₹225.26 | 10,000 | BSE |
30 Jun, 2021 | BHARAT NEMCHAND SHAH | Disposal | ₹ | 10,000 | BSE |
09 Jun, 2021 | Amisha Dipen Kocha | Acquisition | ₹ | 20,500 | BSE |
09 Jun, 2021 | Dina Satish Shah | Disposal | ₹ | 20,500 | BSE |
31 May, 2021 | Bijal Kaushal Shroff | Disposal | ₹126.57 | 10,500 | BSE |
02 Apr, 2021 | Kinjal Siddharth Jhaveri | Acquisition | ₹ | 2,50,000 | BSE |
02 Apr, 2021 | Surekha Bharat Shah | Disposal | ₹ | 1,00,000 | BSE |
Corporate Actions
Announcement Date | Subject | Ex - Date | Record Date |
---|---|---|---|
17 May, 2024 | Rs.2.5000 per share(50%)Final Dividend | 16 Aug, 2024 | 01 Jan, 1970 |
19 May, 2023 | Rs.2.0000 per share(40%)Final Dividend | 11 Aug, 2023 | 01 Jan, 1970 |
16 May, 2022 | Rs.1.7500 per share(35%)Final Dividend | 03 Aug, 2022 | 01 Jan, 1970 |
07 Aug, 2020 | Bonus Issue in the ratio of 1:1 of Rs. 5/- each | 18 Sept, 2020 | 21 Sept, 2020 |
Announcements
Date | Source | Detail |
---|---|---|
13 Feb, 2025 | NSE India | Anuh Pharma Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 |
13 Feb, 2025 | BSE India | Non-applicability of Statement of Deviation(s) and Variation(s) under Regulation 32(1), of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 |
11 Feb, 2025 | NSE India | Anuh Pharma Limited has informed the Exchange regarding Corrigendum to Unaudited Financial Results of the Company for the quarter ended 31st December, 2024 being published on 09th February, 2025, please find enclosed herewith the newspaper cutting for the corrigendum published in Mumbai Lakshdeep (Marathi Language) on 11th February, 2025 |
09 Feb, 2025 | NSE India | Anuh Pharma Limited has informed the Exchange about Copy of Newspaper Publication of the Un-audited financial results for the quarter ended 31st December, 2024, published in the Financial Express in English Language and Mumbai Lakhsdeep in Marathi Language on 09th February, 2025 |
07 Feb, 2025 | NSE India | Integrated Filing - Financials for the Quarter ended 31st December, 2024 |
07 Feb, 2025 | BSE India | Integrated Filing (Financial) for the Quarter ended 31st December, 2024 |
07 Feb, 2025 | NSE India | Anuh Pharma Limited has submitted to the Exchange, the financial results for the period ended December 31, 2024. |
07 Feb, 2025 | BSE India | Un-Audited Financial Results for the Quarter ended 31st December, 2024 |
07 Feb, 2025 | NSE India | Anuh Pharma Limited has informed the Exchange regarding Outcome of Board meeting held on February 07, 2025 with reference to Un-Audited Financial Results and Limited Review Report for the quarter ended 31st December, 2024 |
07 Feb, 2025 | BSE India | To consider and approve the Un-audited Financial Results and Limited Review Report for the Quarter ended 31st December, 2024. |
Board Meetings
Purpose | Details | Meeting Date | Broadcast Date |
---|---|---|---|
Quarterly Results & Others | To consider other business matters. | 19 Feb, 2025 | 07 Feb, 2025 |
Quarterly Results | -- | 30 Oct, 2024 | 08 Nov, 2024 |
Quarterly Results | -- | 05 Aug, 2024 | 09 Aug, 2024 |
Audited Results & Final Dividend | -- | 10 May, 2024 | 17 May, 2024 |
Quarterly Results | -- | 05 Feb, 2024 | 09 Feb, 2024 |
Quarterly Results | -- | 03 Nov, 2023 | 10 Nov, 2023 |
Quarterly Results | -- | 07 Aug, 2023 | 11 Aug, 2023 |
Audited Results & Final Dividend | -- | 15 May, 2023 | 19 May, 2023 |
Quarterly Results | -- | 06 Feb, 2023 | 10 Feb, 2023 |
Quarterly Results | -- | 31 Oct, 2022 | 07 Nov, 2022 |
Share Holding Pattern
Owner Name | Dec, 2024 | Sept, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 |
---|
About Anuh Pharma
Anuh Pharma is a Public Limited Listed company incorporated on 19/02/1960 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH1960PLC011586 and registration number is 011586. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 647.00 Cr. and Equity Capital is Rs. 25.06 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1960
Managing Director
Mr. Ritesh B Shah
NSE Symbol
ANUHPHR
Anuh Pharma Management
Name | Designation |
---|---|
Mr. Arun Todarwal | Chairman & Non-Exe.Director |
Mr. Bipin N Shah | Vice Chairman |
Mr. Ritesh B Shah | Joint Managing Director |
Mr. Vivek B Shah | Joint Managing Director |
Mr. Sandeep Joshi | Independent Director |
Mr. Harmanbhai Patel | Independent Director |
Dr.(Ms.) Mita Dixit | Independent Director |
Mr. Siddharth J Shah | Independent Director |
Mr. Pradeep H Thakur | Independent Director |
Mr. Ketan Shah | Non Executive Director |
Mr. Bharat Shah | Non Executive Director |
Mr. Samir Shah | Non Executive Director |
Mr. Gaurav S Shah | Non Executive Director |
Peer Comparison
Stocks | Market Cap | Market Price | 52 Week Low-High |
---|---|---|---|
Sun Pharmaceutical Industries | ₹4,03,916.05 | ₹1,683.45 ₹1,676.85(0.39%) | ₹1,376.750 - ₹1,960.200 |
Divi's Laboratories | ₹1,49,205.29 | ₹5,620.45 ₹5,667.15(-0.82%) | ₹3,350.050 - ₹6,448.750 |
Cipla | ₹1,18,065.23 | ₹1,461.90 ₹1,454.30(0.52%) | ₹1,317.600 - ₹1,702.000 |
Torrent Pharmaceuticals | ₹1,03,430.62 | ₹3,056.05 ₹3,096.50(-1.31%) | ₹2,488.000 - ₹3,589.950 |
Dr. Reddy's Laboratories | ₹92,453.48 | ₹1,107.95 ₹1,105.15(0.25%) | ₹1,093.000 - ₹1,420.200 |
FAQs on Anuh Pharma
What is the share price of Anuh Pharma?
The share price of Anuh Pharma on 13 Mar, 2025 is ₹ 153.40.
What is 52W high and 52W low share price of Anuh Pharma?
The highest and lowest 52W share prices of Anuh Pharma are ₹ 265.000 and ₹ 151.000
What is the market cap of Anuh Pharma?
The market capitalization of Anuh Pharma as of 13 Mar, 2025 is ₹ 769.32 Crores
What is the P/E ratio of Anuh Pharma?
The current P/E ratio of Anuh Pharma as of 13 Mar, 2025 is 43.95
What is the PB ratio of Anuh Pharma?
The PB ratio of Anuh Pharma as of 13 Mar, 2025 is 2.64
Top Gainers
₹41.02
₹34.29 (0.20%)
₹8.84
₹7.37 (0.20%)
₹6.97
₹5.81 (0.20%)
₹194.70
₹162.25 (0.20%)
Top Losers
₹13.75
₹135.15 (-0.90%)
₹9.60
₹12.00 (-0.20%)
₹9.80
₹93.55 (-0.90%)
₹0.99
₹4.77 (-0.79%)
Market Indices
Sensex
₹73,828.91
₹74,029.76 (0.00%)